DSM.AS - Koninklijke DSM N.V.
| Previous Close | 102.65 |
| Open | 101.70 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 101.70 - 102.85 |
| 52 Week Range | 68.00 - 103.15 |
| Volume | 467,189 |
| Avg. Volume | 699,029 |
| Market Cap | 18.013B |
| Beta (3Y Monthly) | 1.22 |
| PE Ratio (TTM) | 16.92 |
| EPS (TTM) | 6.06 |
| Earnings Date | May 7, 2019 |
| Forward Dividend & Yield | 1.54 (1.59%) |
| Ex-Dividend Date | 2018-08-03 |
| 1y Target Est | 96.08 |
- Simply Wall St.•16 hours ago
What Did Koninklijke DSM N.V.'s (AMS:DSM) CEO Take Home Last Year?
In 2007 Feike Sijbesma was appointed CEO of Koninklijke DSM N.V. (AMS:DSM). This report will, first, examine the CEO compensation levels in comparison to CEO compensation at other big companies. After that, we will consi...
- PR Newswire•21 hours ago
Royal DSM - Repurchase of Shares (15 – 18 April 2019)
HEERLEN, Netherlands , April 23, 2019 /PRNewswire/ -- Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living , has repurchased 123,006 of its own shares in the period from ...
- GlobeNewswire•6 days ago
Amyris Completes Sale of Vitamin E Royalty to DSM
Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced the sale of its Vitamin E royalty agreement to Koninklijke DSM N.V. (Royal DSM) (DSM.AS). This agreement assigns Amyris’s rights to Vitamin E royalties to DSM in exchange for total consideration of approximately $57 million. In addition, DSM and Amyris have agreed to a further manufacturing cooperation for Amyris products at DSM’s Brotas facility that provides additional capacity and lower cost of goods sold with an expected approximate aggregate benefit of $30–$40 million over the next three years.
- PR Newswire•8 days ago
DSM - Repurchase of Shares (8 - 12 April 2019)
HEERLEN, Netherlands , April 16, 2019 /PRNewswire/ -- Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 229,636 of its own shares in the period from ...
GuruFocus.com•11 days ago3 High-Performing Basic-Materials Stocks
Warning! GuruFocus has detected 4 Warning Sign with APD. Further, the following stocks are foreseen to outperform at least their industry within 52 weeks, with Wall Street issuing an overweight recommendation rating on each of them.
- PR Newswire•15 days ago
DSM - Repurchase of shares (1 – 5 April 2019)
HEERLEN, Netherlands , April 9, 2019 /PRNewswire/ -- Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living , has repurchased 144,066 of its own shares in the period from ...
- Simply Wall St.•16 days ago
How Does Koninklijke DSM N.V. (AMS:DSM) Fare As A Dividend Stock?
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Dividends play an important role in compounding returns in the long run and end up forming a sizeable part of investment retu...
- PR Newswire•21 days ago
DSM Executive Committee Members Purchase DSM Shares
HEERLEN, Netherlands , April 3, 2019 /PRNewswire/ -- Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living , announces that all members of its Executive Committee have purchase ...
- PR Newswire•29 days ago
DSM Proposes New Supervisory Board Member
Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, announces that at the Annual General Meeting of Shareholders to be held on 8 May 2019, the DSM Supervisory Board will nominate for appointment as a new Supervisory Board member: Mrs. Erica Mann. The Supervisory Board will also nominate Mrs. Pauline van der Meer Mohr for re-appointment to the Supervisory Board. The aim of these nominations is to maintain and further strengthen the Supervisory Board's profile in terms of international business experience and experience in executive leadership of large corporations.
- PR Newswire•last month
DSM Completes Increase Shareholding in Andre Pectin to 75%
HEERLEN, Netherlands , March 18, 2019 /PRNewswire/ -- Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living , informs its stakeholders that it has completed the increase ...
- PR Newswire•last month
DSM Commences €1 Billion Share Buy-back and Announces Regular Repurchase to Cover Share Plans and Stock Dividend
HEERLEN, Netherlands , March 14, 2019 /PRNewswire/ -- Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living , today announces that it will commence the repurchase of ordinary ...
- PR Newswire•last month
DSM Sets Science-based Reduction Targets for Emissions
Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, announced today that it has set new science-based reduction targets for greenhouse gas emissions. The new targets have been reviewed and approved by the Science Based Targets initiative and aligned with the Paris climate agreement. DSM has committed to reducing 30% of its greenhouse gas emissions from direct production and purchased energy in absolute terms by 2030 compared to 2016.
- PR Newswire•2 months ago
DSM's 2018 Integrated Annual Report: Strong Progress on People, Planet and Profit, Creating Value for All Stakeholders
The report offers all DSM's stakeholders (shareholders, customers, employees, civil society) detailed insights into the company's successful delivery of Strategy 2018, its business development, financial results, environmental and social performance, and corporate governance, as well as its purpose and new Strategy 2021. DSM's purpose-led, performance-driven Strategy 2021 addresses key megatrends and reinforces the company's engagement with the United Nations Sustainable Development Goals (SDGs) through its focus domains of Nutrition & Health, Climate & Energy, and Resources & Circularity.
- Simply Wall St.•2 months ago
Are Koninklijke DSM N.V.’s (AMS:DSM) Returns Worth Your While?
Today we'll evaluate Koninklijke DSM N.V. (AMS:DSM) to determine whether it could have potential as an investment idea. Specifically, we'll consider its Return On Capital Employed (ROCE), since that willRead More...
- PR Newswire•2 months ago
DSM Announces Start of Avansya
HEERLEN, Netherlands , March 1, 2019 /PRNewswire/ -- Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, today announced the establishment of Avansya V.O.F. The 50:50 ...
- Simply Wall St.•2 months ago
Is Koninklijke DSM N.V. (AMS:DSM) Potentially Undervalued?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Koninklijke DSM N.V. (AMS:DSM) saw a significantRead More...
- PR Newswire•2 months ago
DSM Reports 2018 Results
HEERLEN, Netherlands , February 14, 2019 /PRNewswire/ -- Highlights full year 2018 - DSM reports a very strong year, including a robust Q4 - Underlying business: - Strong organic sales growth of ...
- PR Newswire•3 months ago
DSM Announces Agreement to Increase its Shareholding in Andre Pectin From 29% to 75%
Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, informs its stakeholders that it agreed to increase its shareholding in Yantai Andre Pectin Co. Ltd. (Andre Pectin) to 75%. DSM acquired a 29% stake in Andre Pectin in 2013. After settling a shareholders dispute, DSM has now agreed with the other shareholders to purchase an additional 46% stake in Andre Pectin for a consideration of about €150 million.
- PR Newswire•3 months ago
DSM Announces New Chief Innovation Officer
HEERLEN, Netherlands , January 31, 2019 /PRNewswire/ -- Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living , today announced that Rob van Leen , Chief Innovation Officer ...
- PR Newswire•3 months ago
DSM Announces JV With Nenter to Produce Vitamin E
HEERLEN, Netherlands , January 29, 2019 /PRNewswire/ -- Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living , today announced that it intends to create a 75/25 joint venture ...
- Simply Wall St.•3 months ago
Why Fundamental Investors Might Love Koninklijke DSM N.V. (AMS:DSM)
Building up an investment case requires looking at a stock holistically. Today I've chosen to put the spotlight on Koninklijke DSM N.V. (AMS:DSM) due to its excellent fundamentals in more Read More...
- Simply Wall St.•3 months ago
Is Koninklijke DSM N.V.’s (AMS:DSM) Liquidity Good Enough?
With a market capitalization of €12b, Koninklijke DSM N.V. (AMS:DSM) is a large-cap stock, which is considered by most investors as a safe bet. Common characteristics for these big stocks Read More...
- Simply Wall St.•4 months ago
Does Koninklijke DSM N.V.’s (AMS:DSM) P/E Ratio Signal A Buying Opportunity?
This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios). To keep it practical, we'll show how Koninklijke DSM N.V.'s (AMS:DSM) Read More...
- Simply Wall St.•5 months ago
What Can We Expect From Koninklijke DSM NV’s (AMS:DSM) Earnings In The Year Ahead?
In September 2018, Koninklijke DSM NV (AMS:DSM) released its earnings update. Generally, analyst consensus outlook appear pessimistic, with profits predicted to drop by -12% next year relative to the past Read More...
- Simply Wall St.•5 months ago
What Price Should You Be Buying Koninklijke DSM NV’s (AMS:DSM)?
Choosing the right financial tool to evaluate a company can be a daunting task, especially when different models are giving you drastically different conclusions. For example, my discounted cash flow Read More...
